Key result
A mouse model of nemaline myopathy carrying the human Met9Arg mutation of Tpm3 demonstrated elevated markers of satellite cells and immature fibers, indicating a novel repair process.
Answers are grounded in this paper and cite their sources.
Does not support clinical translation; leaves open a novel satellite cell repair mechanism in nemaline myopathy for human validation.
Nemaline myopathy (NM), the most common non-dystrophic congenital myopathy, is a variably severe neuromuscular disorder for which no effective treatment is available. Although a number of genes have been identified in which mutations can cause NM, the pathogenetic mechanisms leading to the phenotypes are poorly understood. To address this question, we examined gene expression patterns in an NM mouse model carrying the human Met9Arg mutation of alpha-tropomyosin slow (Tpm3). We assessed five different skeletal muscles from affected mice, which are representative of muscles with differing fiber-type compositions, different physiological specializations and variable degrees of pathology. Although these same muscles in non-affected mice showed marked variation in patterns of gene expression, with diaphragm being the most dissimilar, the presence of the mutant protein in nemaline muscles resulted in a more similar pattern of gene expression among the muscles. This result suggests a common process or mechanism operating in nemaline muscles independent of the variable degrees of pathology. Transcriptional and protein expression data indicate the presence of a repair process and possibly delayed maturation in nemaline muscles. Markers indicative of satellite cell number, activated satellite cells and immature fibers including M-Cadherin, MyoD, desmin, Pax7 and Myf6 were elevated by western-blot analysis or immunohistochemistry. Evidence suggesting elevated focal repair was observed in nemaline muscle in electron micrographs. This analysis reveals that NM is characterized by a novel repair feature operating in multiple different muscles.
No takes yet. Share an insight, caveat, or question.
Sanoudou et al. (2006) studied Nemaline myopathy. Met9Arg mutation of alpha-tropomyosin slow (Tpm3) vs. Non-affected mice was evaluated on Gene expression patterns and markers of muscle repair. A mouse model of nemaline myopathy carrying the human Met9Arg mutation of Tpm3 demonstrated elevated markers of satellite cells and immature fibers, indicating a novel repair process.
Synapse has enriched 10 related papers. Consider them for comparative context: